We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Robert F Kennedy Junior’s appointment as US health czar means an unpredictable time for ASX healthc...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a strong session on Tuesday and is storming higher....
Read ArticleSonic reaffirms earnings guidance and says it is on the hunt for “sensible” acquisitions Boards fac...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleHarvard University’s teaching hospital will adopt Echo IQ’s AI-based aortic stenosis detection tool...
Read ArticleAmid improving sector sentiment, Actinogen says its Alzheimer’s trial is off to a flier Telix share...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleIt's been a rough session for the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 shares so far th...
Read ArticleWellnex Life Ltd (ASX:WNX) has unveiled its plans to defer a $2.95M payment to 360 Health until it l...
Read ArticleHighlights ASX200 closed up, led by gains in IT and Utilities sectors. Leadership shake-up affe...
Read ArticleHighlights ASX closed with a 0.56% gain, boosted by Utilities and IT sectors. Notable gains...
Read ArticleThe ASX200 closed up 0.56% at 8164 points. In a tumultuous day on the market, Chris Ellison’s Min...
Read ArticleHighlights ASX rises as banks drive gains amid strong Wall Street influence. MinRes faces maj...
Read ArticleIt was a very pleasant start to what is shaping up to be...
Read ArticleASX closes higher despite Mineral Resources dip US dollar weakens amid uncertain election pollin...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is starting the week strongly. In afternoon trade, the benchm...
Read ArticleHighlights ASX gains slightly amid mixed performances in key sectors Mineral Resources dro...
Read ArticleTelix Pharmaceuticals will benefit from ongoing favourable US pay arrangements for high-value radio...
Read ArticleHighlights ASX rises, supported by tech and utilities sectors, despite mining and banking press...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares are starting the week strongly. In morning trade, the AS...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) ended the...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) endured a w...
Read ArticleAt 11:40am, the S&P/ASX 200 is 0.24 per cent lower at 8,229.60. The SPI futures are pointing to...
Read ArticleAt 11:30am, the S&P/ASX 200 is 0.39 per cent higher at 8,253.30. The SPI futures are pointing to...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) enjoyed a bo...
Read ArticleGet our share tips straight to your inbox – Sign Up Here John Edwards, Novus Capital BUY RECOMMEND...
Read ArticleThe ASX200 closed down 0.12% at 8,206 points. In breaking news, the founder of Wisetech Richard W...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) had a wild, but...
Read ArticleASX ends very modestly lower after a mixed session Newmont and Fortescue shares drop on disappoint...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. In afternoon...
Read ArticleTelix Pharmaceuticals’ brain cancer diagnostic could leapfrog over its kidney cancer assay to be it...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Thursday morning. In morning trade, the...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleNot every S&P/ASX 200 Index (ASX: XJO) stock is going to shoot the lights out and deliver 10-ba...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) endured a fairly mi...
Read ArticleHighlights ASX falls as weak Chinese economic data hits commodity stocks. Gold miners rally whi...
Read ArticleA top ASX stock is heading off to try its fortunes on the Nasdaq Composite Index (NASDAQ: .IXIC)....
Read ArticleTelix Pharmaceuticals (ASX:TLX) reveals its quarterly revenues while also reaffirming its full-year...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX closes higher led by Wall Street gains ReNu Energy reveals partial offer for hydrogen asset...
Read ArticleCancer drug developer Chimeric Therapeutics eyes minimum $5 million raising ‘The next Telix’, Clari...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleBig biotech names support Island Therapeutics raising Radiopharm eyes FDA approval to start a thera...
Read ArticleBiome Australia believes it can almost quadruple its probiotics revenue over next three years Ante...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has been on form this year and has recorded a solid gain. Sin...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleASX healthcare sector shows signs of recovery after latest earnings season Pathology and aged care...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe Australian sharemarket experienced a decline from record highs, primarily due to investor concer...
Read ArticleMelbourne-based biotech Telix Pharmaceuticals (ASX: TLX) has expanded its North American manufacturi...
Read ArticleTelix Pharmaceuticals Limited (ASX: TLX), a prominent oncology company specializing in radiopharmace...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares are falling on Monday morning. At the time of writing, t...
Read ArticleThe ASX 200 is forecasted to experience a downturn, with futures down 0.8% to 8190 points, following...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleMelbourne-based Telix Pharmaceuticals Ltd (ASX:TLX) is set to expand its manufacturing and distribut...
Read ArticleAus shares have reached a record high, while Myer highlights challenging market conditions. Regis He...
Read ArticleAt 11:40am, the S&P/ASX 200 is 0.23 per cent higher at 8,140.50. This comes amid expectations of...
Read ArticleThe Australian sharemarket briefly touched a new record high on Monday, mirroring a surge in US stoc...
Read ArticleAt 11:35am, the S&P/ASX 200 is 0.37 per cent higher at 8,130.20, buoyed by a rally on Wall Stree...
Read ArticleAlive and Kicking is renowned biotech journo Tim Boreham’s new daily wrap covering morning movers an...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleInvestors are keeping a close eye on several S&P/ASX 200 Index (ASX: XJO) shares, with two parti...
Read ArticleBelow, we look at two compelling S&P/ASX 200 Index (ASX: XJO) shares you may wish to consider ad...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleAustralian shares opened higher, buoyed by a rise in tech stocks, particularly Tesla and Amazon, whi...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleNoxopharm says two novel drug candidates significantly reduced glioblastoma (brain cancer) cell gro...
Read ArticleIn the first session of the week, the Australian sharemarket is experiencing a decline, primarily dr...
Read ArticleTelix Pharmaceuticals (ASX:TLX) CEO and co-founder Dr Chris Behrenbruch is blunt about why some fund...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe Australian share market closed flat on Wednesday, with consumer staples offsetting losses in com...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced its receipt of fast track status from the US FDA withi...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares are drifting higher on Tuesday, extending gains to 98% f...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price...
Read ArticleFor chief executives and institutional investors, the critical phase of earnings season begins after...
Read ArticleAustralian shares are poised to end a 10-day winning streak on Friday, with the market opening down...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the move on Friday morning. At the time o...
Read ArticleOn Thursday, the S&P/ASX 200 Index (ASX: XJO) recorded a modest gain, rising 0.2% to close at 8,...
Read ArticleOn Thursday, the S&P/ASX 200 Index (ASX: XJO) had another decent session and recorded a small...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleAt 11:40am, the S&P/ASX 200 is 0.07 per cent lower at 7,965.9, the Australian share market opene...
Read ArticleAt 11:30am, the S&P/ASX 200 is 1.39 per cent higher at 7,974.5, driven by optimism about potenti...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleIt's been a bouncy, yet positive session for the S&P/ASX 200 Index (ASX: XJO) and most ASX 200 s...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) comprises 11 market sectors, and the outperformer over the p...
Read ArticleAt 11:40am, the S&P/ASX 200 is 0.2 per cent higher at 7,695.60. Michele Bullock's calm and stead...
Read ArticleThe Australian sharemarket rebounded today after heavy selling yesterday. At noon, the S&P/ASX 2...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe Australian sharemarket surged 1.8% on Wednesday, driven by unexpectedly low inflation figures, q...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a tumble today. Shares in the S&am...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on track to record a strong gain on Wednesday. At the time...
Read ArticleAustralian annual inflation increased to 3.8% in the June quarter, aligning with market expectations...
Read ArticleASX healthcare shares are often touted here on the Australian share market. We are home to some of t...
Read ArticleNova Minerals (ASX:NVA) shares dipped nearly -3% in Friday morning trades after announcing it was cl...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) endured yet anothe...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe Australian sharemarket fell on Wednesday, with the S&P/ASX 200 Index dropping 0.1% due to de...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is experiencing a lackluster session on Wednesday, with the ben...
Read ArticleAustralian shares experienced a decline at midday, following a downward trend in US markets. The ben...
Read ArticleAs of 8:30 am AEST, ASX 200 futures are trading 11 points higher, up 0.13%. Overnight, major US be...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) endured a tough sta...
Read ArticleOn Monday, Australian shares declined due to concerns over the potential impact of US President Joe...
Read ArticleAustralian shares fell 0.8% at the open, influenced by upcoming US tech earnings and President Joe B...
Read ArticleThe S&P/ASX 200 (ASX: XJO) fell on Thursday, following a global lead that was driven by the sell...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) experienced a slight setback on Thursday, ending its recent win...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe ASX healthcare stock in this article has been on fire over the past 12 months. During this time,...
Read ArticleOn Thursday, the S&P/ASX 200 Index (ASX: XJO) snapped its winning run with a small decline. Th...
Read ArticleThe ASX200 closed down 0.27% at 8036 points, as the Australian market pulled back from yesterday’s r...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is rising again on Thursday morning. In early t...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares were a standout performer on the ASX in FY24, rallying m...
Read ArticleASX 200 punches through 8,000 on Monday All sectors higher Small cap miners led by Aldoro Resourc...
Read ArticleThe ASX200 had a strong day closing up 0.93%. All sectors closed in the green with top performer ...
Read ArticleASX 200 punches it, record highs back in view 11 of 11 sectors higher, like a well-oiled machine...
Read ArticleThe Australian sharemarket experienced a risk-on day, with the benchmark briefly climbing above 7900...
Read ArticleWhilst the All Ordinaries Index (ASX: XAO) is up less than 1% on Thursday, three ASX All Ords shares...
Read ArticleThe ASX200 has performed strongly so far today, gaining about 0.9%. This has come in the wake of...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced its prostate cancer imaging drug Illuccix won’t be neg...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has surged more than 12% in response to positiv...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is back on form and rising strongly on Thursday. In afternoon...
Read ArticleAustralian shares opened strongly, rising 1.1% to surpass 7900 points, nearing a record high set in...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is back on form and roaring higher on Thursday. At the time o...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a very strong session on Thursday. In...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe Netwealth Group Ltd (ASX: NWL) share price is pushing higher on Thursday. In morning trade, the...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleIn this article, we examine the best ASX 200 healthcare shares of FY24 based on share price growth....
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleS&P/ASX All Ords (ASX: XAO) shares rose by 0.54% in June. It's interesting to see a very larg...
Read ArticleOn Monday, the Australian sharemarket initially declined slightly with the S&P/ASX 200 Index clo...
Read ArticleLooking for exposure to the healthcare sector in FY 2025? If you are, then check out the three ASX s...
Read ArticleAustralian shares climbed across the board on Tuesday, with the S&P/ASX 200 Index rebounding 1.4...
Read ArticleFancy grabbing a 917% one-year return from your ASX healthcare stock investment? Me too! The...
Read ArticleAustralian shares closed marginally lower on Wednesday despite a rise in energy stocks, with the S&a...
Read ArticleAustralian shares saw modest declines despite gains in energy stocks, with the overall index experie...
Read ArticleAt 11:30am, the S&P/ASX 200 is 0.92 per cent higher at 7,771.10, mirroring a continued surge in...
Read ArticleAustralian shares fell on Monday, with the benchmark S&P/ASX 200 closing 0.3% lower, led by decl...
Read ArticleAustralian job advertisements, as measured by ANZ-Indeed, decreased by 2.1% in May, following a peak...
Read ArticleASX200 dropped on Friday, extending its weekly loss despite Wall Street’s highs Telix Pharma halted...
Read ArticleTelix Pharmaceuticals (ASX: TLX), one of the nation’s largest biotechnology companies, has announced...
Read ArticleASX health stocks fall in past five days in line with broader markets on mixed economic signals The...
Read ArticleThe ASX200 is trading down around 0.3%. The discretionary sector has made gains of 0.3%, all othe...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is down after shelving its plan to list in the...
Read ArticleInternational growth plans for Telix Pharmaceuticals (ASX:TLX) – proudly boasting its intentions to...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a fall today. Shares in the S&...
Read ArticleThis article was originally published on Fool.com. All figures quoted in US dollars unless otherwise...
Read ArticleAlthough Telix Pharmaceuticals Ltd (ASX: TLX) shares have been on fire over the last 12 months, they...
Read ArticleASX rises +0.5pc driven by tech, banking, and property sectors This comes as US Fed maintains rates...
Read ArticleUp 63% so far in 2024, the Telix Pharmaceuticals Ltd (ASX: TLX) share price isn't going anywhere tod...
Read ArticleLooking for some top S&P/ASX 200 Index (ASX: XJO) stocks to tap into the massive growth potenti...
Read ArticleAt 11:30am, the S&P/ASX 200 is 1.27 per cent lower at 7,760.30, mirroring losses in Europe due t...
Read ArticleThe performance of the healthcare sector has been relatively underwhelming in recent times. While th...
Read ArticleLooking to invest in an ASX biotech share with the potential to become the next Telix Pharmaceutical...
Read ArticleAustralian shares opened with a 0.2% increase driven by gains in mining sectors like iron ore, lithi...
Read ArticleASX investors woke today to news that the European Central Bank had cut interest rates. In a broadly...
Read ArticleGiven June is upon us, so too is tax time… along with the moons and Ferris wheels. It's natural for...
Read ArticleS&P/ASX 200 Index (ASX: XJO) investors hoping for interest rate relief from the Reserve Bank of...
Read ArticleThe European Lithium Ltd (ASX: EUR) share price has been a strong performer on Thursday. At the time...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has caught the eye of investors on Thursday. In...
Read ArticleBy Rudi Filapek-Vandyck, EditorSo far this year, ResMed ((RMD)) shares are down -4.4%, with Cochlear...
Read ArticleMorgan Stanley and Jefferies are among the managers overseeing Telix Pharma’s (ASX:TLX) freshly comm...
Read ArticleThe Australian market is tipped to open higher this morning, with futures up 52.3 points at 8:49 AES...
Read ArticleBy Tim Boreham, Editor, The New Criterion ASX code: ((ATX)) Market cap: $17.93m Shares on issue: 271...
Read ArticleOverseas markets rallied in May on lower bond yields and stabilising inflation prints, but the Austr...
Read ArticleWealth Within analyst Filip Tortevski has been eyeing some big gun miners whose stock has been falli...
Read ArticleAus shares began the session with minimal change, leveling off shortly after the market opened. This...
Read ArticleThe big news in shares vs. property is Brisbane overtaking Canberra as Australia's second-most expen...
Read ArticleThree S&P/ASX 200 Index (ASX: XJO) stocks did more than their fair share of the heavy lifting i...
Read ArticleINOVIQ’s exosomes therapy to target breast cancer cells INOVIQ (ASX:IIQ) said it has created special...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has bounced back into the green today. Share...
Read ArticleWhat grabbed the headlines last week? Major global share markets fell over the last week, as high...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) had a relatively decent time in May. During the month, the ben...
Read ArticleMelbourne-based Telix Pharmaceuticals Ltd (ASX:TLX) has reported that data from recent tests on TLX5...
Read ArticleThe ASX200 is trading up around 0.55% With strong performances from major medical companies, the...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positiv...
Read ArticleFDA approves AVITA’s RECELL GO System Wound care medical company, AVITA Medical ASX:AVH), surged +13...
Read Article31 May 2024 - A snapshot of the stocks on the move, featuring Telix Pharmaceuticals (ASX:TLX), AVITA...
Read ArticleAt 11:30am, the S&P/ASX 200 is 0.49 per cent higher at 7,665.70, following a three-day sell-off,...
Read ArticleTo register for today's webinar click here. Telix Pharmaceuticals (ASX:TLX) announces additional p...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher today. Shares in the S&...
Read ArticleThe ASX200 is set to rise by +0.80% on Friday following a lacklustre week for the bourse. The USA...
Read ArticleASX biotech shares have been showing significant signs of momentum lately. Exciting clinical trial r...
Read ArticleIn this week’s video insight, I discuss the remarkable progress of Telix Pharmaceuticals (ASX:TLX)....
Read ArticleIn this week’s video insight, I discuss the remarkable progress of Telix Pharmaceuticals (ASX:TLX)....
Read ArticleEMVision’s AI algorithm shows promise EMvision Medical Devices (ASX:EMV) has shared an update from i...
Read ArticleTelix Pharmaceuticals has submitted a new drug application to the United States Food and Drug Admini...
Read ArticleTelix (ASX:TLX) has announced the successful completion of CUPID, a first-in-human Phase 1 d...
Read ArticleI had the pleasure of joining Adam Keily on the ‘Equity Mates’ podcast, where we had a great discuss...
Read ArticleThe ASX200 slipped into the red at close, 0.05 of a per cent down with industrials gaining 0.49% and...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain on Wednesday. In afternoo...
Read ArticleSeven S&P/ASX 200 Index (ASX: XJO) shares are leaping to 52-week highs today. Yep, seven! Their...
Read ArticleThe ASX200 closed just 12 points down (0.15%) as the local markets shrugged off another record close...
Read ArticleIt’s been a busy day at the Australian Energy Producers conference in Perth, where the morning’s gue...
Read ArticleTelix says TLX592 is effective on prostate cancer Telix Pharmaceuticals (ASX:TLX) has today announce...
Read ArticleThe Reserve Bank's May policy meeting minutes indicated that while raising the cash rate was conside...
Read ArticleThe ASX200 closed around 0.63% up with energy soaring 2.3% and materials 1.9%. The poorest perfor...
Read ArticleThe ASX200 is up 0.65% – in line with futures’ predictions. Healthcare is down 0.4% – whilst mat...
Read ArticleTelix Pharmaceuticals (ASX:TLX) announced on Monday it has filed early-stage paperwork proposing to...
Read ArticleGiven the topic, let's try to keep this article as light-hearted as possible. Let's assume that one...
Read ArticleBell Potter says biotech very much a non-cyclical performer driven by catalysts including clinical...
Read ArticleTwo ASX shares that have made their shareholders smile this year are DroneShield Ltd (ASX: DRO) and...
Read ArticleAustralian shares closed higher on Tuesday, with the S&P/ASX 200 advancing 0.4% to 7664.1 points...
Read ArticleCompanies discussed include: Telix Pharmaceuticals (ASX:TLX)Bank of Queensland (ASX:BOQ)MAAS Group...
Read ArticleOne ASX healthcare stock is clocking a new record price today while the S&P/ASX 200 Index (ASX:...
Read ArticleIn the dynamic landscape of investing, uncovering hidden gems amidst the sea of opportunities often...
Read ArticleASX health stock fall in past five days in line with broader markets as economic and geopolitical f...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is back on form and pushing higher on Thursday. In afternoon t...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking off on Thursday morning. At the time...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has reported an 18 per cent increase in revenue for the firs...
Read ArticleOn Wednesday, the S&P/ASX 200 Index (ASX: XJO) fought hard but fell short at the final hurdle...
Read ArticleMELBOURNE, Australia, April 17, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleAfter shedding nearly double what futures had predicted, the ASX200 closed the day 1.8 per cent down...
Read ArticleThe ASX200 has shed nearly double what futures predicted, trading down 2.05% All 11 sectors are i...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a day to forget on Tuesday. In afternoon trade, the b...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has been granted Fast Track designation by The United States Food an...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Tuesday. In morning trade, the ASX 200 hea...
Read ArticleThe US FDA has granted fast-track designation to Telix Pharmaceuticals (ASX:TLX) investigati...
Read ArticleThe pain’s set to intensify today, with a 0.8 per cent fall predicted on the ASX200. Retail sales...
Read ArticleFDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging Collaborati...
Read ArticleThere could be some big returns on offer in the healthcare sector for Australian investors according...
Read ArticleOn Thursday, the S&P/ASX 200 Index (ASX: XJO) had a tough session and dropped into the red. Th...
Read ArticleThe ASX200 is up nearly half a per cent – slightly beating futures predictions – with materials lead...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has acquired one of its service suppliers – IsoTherapeutics Group –...
Read ArticleThe ASX200 is set to continue its upward run today, with futures pointing to a .41 per cent lift....
Read ArticleThe ASX200 has closed down .56 of a per cent with IT down 1.4 per cent and in the red for a second s...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO)Â wrapped up t...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a disappointing finish to the week. In afternoon tr...
Read ArticleEveryone remembers their first time. If you have never done it before, buying ASX shares can be a s...
Read ArticleMELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 /PRNewswire/ — Telix Pharmaceuticals Li...
Read ArticleWith the S&P/ASX 200 Index (ASX: XJO) rocketing more than 14% since the start of November, stoc...
Read ArticleASX growth shares that are soaring rapidly are obviously exciting and rewarding to own. But, of cou...
Read ArticleMELBOURNE, Australia, March 12, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares are up approximately 75% over the last 12 months. Inves...
Read ArticleOn Friday, the S&P/ASX 200 Index (ASX: XJO) ended the week at a record high close. The benchm...
Read ArticleJust $9,000 could start your journey into the delicious world of passive income. In fact, I reckon...
Read ArticleThe ASX 200 traded sideways on Tuesday, closing the day flattish as gains in healthcare stocks were...
Read ArticleAustralian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is set to acquire Canadian rad...
Read ArticleTelix (ASX:TLX) will acquire radioisotope production technology firm ARTMS, its advanced cyc...
Read ArticleMELBOURNE, Australia, March 5, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleTelix Pharmaceuticals strengthens its global presence by acquiring Texas-based IsoTherapeutics Is...
Read ArticleTelix (ASX:TLX) has announced total group revenue of $502.5 million for the 12 months to the...
Read ArticleMELBOURNE, Australia, Feb. 27, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AX1)) - Ac...
Read ArticleASX gains on Nvidia-fuelled rally AI adjacent stocks, such as data centre companies, also surge Aft...
Read ArticleMelbourne-based radiation oncology business Telix Pharmaceuticals has made its first-ever profit aft...
Read ArticleMELBOURNE, Australia, Feb. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleOf course, here at The Motley Fool we always recommend investors practise proper diversification to...
Read ArticleWhen you're running your slide rule over S&P/ASX 200 Index (ASX: XJO) stocks to add to your por...
Read ArticleIf you're willing to put up with a little bit more risk than the average, there are some ASX stocks...
Read ArticleASX gained ground as the S&P 500 reached record highs AI mania continues as Arm Ltd surges 20pc...
Read ArticleThe ASX200 is set to trade flattish today with a mixed night on Wall Street, itself currently absorb...
Read ArticleMELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleI discussed earlier this month how it took a while for Tesla Inc (NASDAQ: TSLA) to become a brand n...
Read ArticleSure, a million bucks no longer gets you an average house in Sydney. But becoming a millionaire sti...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticleThe Australian stock market concluded the trading session on a positive note on Tuesday, propelled b...
Read ArticleThe ASX200 has added .83 per cent today… fuelled largely by the energy sector which rallied more tha...
Read ArticleASX lifted on the back of commodities rally overnight Most energy and mining stocks rose Telstra do...
Read ArticleTelix Pharmaceuticals (ASX:TLX) is set to acquire a private US company QSAM Biosciences develops...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced that the first patient has been dosed in its P...
Read ArticleMELBOURNE, Australia, Nov. 14, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleMELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX:...
Read ArticleMELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleMELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleShares higher after US Fed’s decision to keep rates steady Rates-sensitive stocks, like Tech and Re...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes and updates...
Read ArticleThere's no need to wait for the Boxing Day sales to pick up some mega stocktake bargains. Plenty of...
Read ArticleTelix Pharmaceuticals has seen a 25% drop in its share price in the past four days as the market tur...
Read ArticleThe wall of worry continues to pressure the Australian share market with the escalating conflict sen...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticleThe ASX200 has fallen more than 1.3 per cent today to sit well below the 7000 point mark and all 11...
Read ArticleAustralia’s latest labour force data has dropped and employment remains historically strong with une...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is getting punished today as investors respond...
Read ArticleLast night's trading on the United States markets saw something rather incredible happen with the N...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a day to forget on Thursday. In afternoon trade, th...
Read ArticleTelix Pharma down 17pc despite showing positive Q3 growth metrics Emyria to import MDMA to Australi...
Read ArticleTelix (ASX:TLX) shareholders are likely today putting their phones down and walking away from the ta...
Read ArticleOn Wednesday, the S&P/ASX 200 Index (ASX: XJO) was on form again and recorded a decent gain....
Read ArticleMELBOURNE, Australia, Oct. 18, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleA passive income of $200 each week for the rest of your life would be pretty handy for most Austral...
Read ArticleMELBOURNE, Australia and LIEGE, Belgium, Sept. 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limi...
Read ArticleIf you're already reading The Motley Fool, then you already have some idea that ASX growth shares a...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleFancy having a million dollars to your name? Even though there is only a $5 difference between havi...
Read ArticleFancy having a million dollars to your name? Even though there is only a $5 difference between havi...
Read ArticleAccording to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO...
Read ArticleThe radiopharmaceuticals outfit’s market valuation has been irradiated since it raised a record $92...
Read ArticleIt's been a happy end to the trading week indeed for the...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) had another shaky day...
Read ArticleIt has been another busy week for Australia's top brokers. This has led to the release of a large n...
Read ArticleIt's been another horrid day for the S&P/ASX 200 Index (AS...
Read ArticleLocal shares slumped by more than 1.1pc today All 11 sectors were down, led by BHP and Allkem Phil...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) seems to be starting a run...
Read ArticleMELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleIn this week's Weekly Insights:-Outlook Negative, With Plenty Of Silver Linings-Conviction Calls &am...
Read ArticleDamian Cottier dives into why and how ASX investors can use ESG principles to their advantage, and o...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ABB)...
Read ArticleDo you have $20,000 saved that you could invest in ASX shares? If so, I reckon you could turn it in...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has ended its three-day winning...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At...
Read ArticleThese four ASX healthcare shares are bucking the trend today with strong share price gains followin...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a strong session. At the time of wri...
Read ArticleTelix (ASX:TLX) has reported total revenue of $220.8 million for the six months to the end o...
Read ArticleMELBOURNE, Australia, Aug. 23, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleBuying any S&P/ASX 200 Index (ASX: XJO) stock undoubtedly comes with risks. But if you pick the...
Read ArticleMELBOURNE, Australia, Aug. 11, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleTelix Pharmaceuticals (TLX) doses its first Chinese patient in the phase III study of TLX591-CDx (Il...
Read ArticleMELBOURNE, Australia, Aug. 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleHow do you spot multibagger stocks? Which sectors can you find them in, and which ASX stocks have g...
Read ArticleChina’s export controls on gallium and germanium come into effect today with licensing procedures wi...
Read ArticleOncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports. By Tim Bor...
Read ArticleAustralian Eagle Asset Management is the top performing fund manager over a five-year period with th...
Read ArticleIn this week's Weekly Insights:-Opportunities With A Five Year Horizon-Company Reports: Early Trends...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has suffered a disappointing start to the trading week t...
Read ArticleThe ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks...
Read ArticleShares closed flattish as Aussie jobless rate falls to 3.5% Earnings season heats up as a handful o...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on form again and on track to record a small gain. In aft...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has come under pressure on Thursday. In mornin...
Read ArticleWorld Overnight SPI Overnight 7286.00 + 2.00 0.03% S&P ASX 200 7323.70 + 39.90 0.55% S&a...
Read ArticleMELBOURNE, Australia, July 19, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleMELBOURNE, Australia, July 19, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleHighlights Telix Pharmaceuticals is a radiopharmaceutical company focusing on the development of...
Read ArticleFancy getting money without having to work for it? So do I. Believe it or not, it is possible for...
Read ArticleTelix Pharmaceuticals Limited (ASX:TLX) is a Melbourne-headquartered $3.9 billion company which rece...
Read ArticleWhat will the second half have in store for investors? How investors can play geopolitics and reces...
Read ArticleFrom box televisions to the World Wide Web, and brick phones to smartphones, artificial intelligence...
Read ArticleIn this week’s video insight David Buckland discusses two Australian biomedical companies, Pro-Medic...
Read ArticleThe last financial year was a good one for the S&P/ASX 200 Index (ASX: XJO). The benchmark in...
Read ArticleIt has been another busy week for Australiaâs top brokers. This has led to the release of a large...
Read ArticleOn Thursday, the S&P/ASX 200 Index (ASX: XJO) ran out of steam and edged into the red. The be...
Read ArticleTelix (ASX:TLX) has released further details of the positive results from its completed pivo...
Read ArticleMELBOURNE, Australia, June 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleWilsons equity strategist Rob Crookston is a happy man. Despite the turbulence in the general marke...
Read ArticleAvita Medical receives US FDA premarket approval for its RECELL System to treat vitiligo Telix will...
Read ArticleThe Imugene Limited (ASX: IMU) share price has continued downward in the last 12 months, with the c...
Read ArticleMELBOURNE, Australia, June 22, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleAfter the S&P/ASX 200 Index (ASX: XJO) broke its near-two week winning streak yesterday, th...
Read ArticleMELBOURNE, Australia, June 21, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has sadly broken its near-two-week winning streak this Wedn...
Read ArticleThe ASX 200 index slumped by almost half a percent Energy stocks retreated, while Telstra, QBE, Woo...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, June 21, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleTelix (ASX:TLX) has announced that the first patient has been dosed in a global Phase 2 stud...
Read ArticleThe ASX was trading positively at midday, up almost 0.7 per cent. Most sectors secured gains, wit...
Read ArticleTelix Pharmaceuticals (TLX) doses the first patient for its phase II Starburst study for treating a...
Read ArticleMELBOURNE, Australia, June 19, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has ended the trading week on a very high high this Friday....
Read ArticleJune 21, 2023, at The Yale Club, New York City Featured speakers and Key Opinion Leaders include...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has closed after another positive session this Wednesday. Fol...
Read ArticleAfter a shaky start in the red this morning, the S&P/ASX 200 Index (ASX: XJO) ended up closing...
Read ArticleTelix (ASX:TLX) has officially opened its radiopharmaceutical production facility in Brussel...
Read ArticleAustralia’s second-largest biotechnology company by revenue behind CSL (ASX: CSL), Telix Pharmaceuti...
Read ArticleTelix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part...
Read ArticleMELBOURNE, Australia, June 6, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleThe final day of the trading week saw the ASX finish in the green up 0.48 per cent. This comes af...
Read ArticleAfter starting the day off on the wrong foot, the S&P/ASX 200 Index (ASX: XJO) tumbled even fur...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) traded in the red for much of Tuesday, ending the session 0.11...
Read ArticleIt has been a great start to the week for the S&P/ASX 200 Index (ASX: XJO). In afternoon trade...
Read ArticleJune 21, 2023, at The Yale Club, New York City The Company will showcase its urologic pipeline, d...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) tumbled on Thursday, falling 1.05% to close at 7,138.2 points....
Read ArticleWorld Overnight SPI Overnight 7241.00 – 35.00 – 0.48% S&P ASX 200 7259.90 – 3.40 – 0.05%...
Read ArticleAfter spending all day in the green, the S&P/ASX 200 Index (ASX: XJO) posted a last-minute fall...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is in the green on Tuesday, thanks in part to three stocks eac...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) spent Tuesday in the red, closing the day 0.45% lower at 7,234...
Read ArticleMaybe you are sick of hearing this, but it doesn’t make it any less true: it’s a turbulent time for...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) slipped lower once more on Thursday, falling 0.05% to close at...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) slumped on Wednesday, dropping 0.12% to close at 7,255.7 point...
Read ArticleS&P/ASX 300 Index (ASX: XKO) shares have returned an average of 18.8% over the past five years....
Read ArticleTelix (ASX:TLX) has agreed with Bayer to supply its Illuccix for a Phase 3 ARASTEP study inv...
Read ArticleMELBOURNE, Australia, May 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleMELBOURNE, Australia and KYOTO, Japan, May 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (...
Read ArticleASX 200 healthcare share Telix Pharmaceuticals Ltd (ASX: TLX) has had a stellar month. The Telix P...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) plummeted on Tuesday, dropping 0.92% to finish the session at...
Read ArticleMELBOURNE, Australia, May 2, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleThe ASX jumped half a percent, tracking moves in New York on Friday Three major decisions by centra...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has started the week in a positive fashion. In afternoon tra...
Read ArticleTelix Pharmaceuticals (TLX) reveals new “positive” results from its phase III ZIRCON study of its TL...
Read ArticleMELBOURNE, Australia, May 1, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleTelix Pharmaceuticals (TLX) expands its artificial intelligence (AI) capability through the acquisit...
Read ArticleStock in S&P/ASX 200 Index (ASX: XJO) biopharma company Telix Pharmaceuticals Ltd (ASX: TLX) is...
Read ArticleThe ASX is on Thursday expected to follow the US Dow Jones index, which declined overnight following...
Read ArticleAfter starting off deep in the red, the S&P/ASX 200 Index (ASX: XJO) regained some ground to cl...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) closed the week in the red, falling 0.43% in Fridayâs sessio...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has followed Wall Streetâs lead and is on course to end th...
Read ArticleASX health stocks fall 0.32% in the past five days, despite rise in broader markets Neuren Pharmace...
Read ArticleHighlights: The Australian benchmark index S&P/ASX 200 index, has decreased by 2.64% in the...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) traded relatively flat for most of Thursday, finishing the ses...
Read ArticleAustralian radiopharmaceutical company Telix (ASX:TLX) has delivered its first $100 million...
Read ArticleThe ASX ended the day in the green, but Asian markets didn’t quite cross the line. The ASX 200 cl...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) had a rocky session on Wednesday, ultimately closing 0.07% hig...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a tiny gain. At th...
Read ArticleASX 200 stock Telix Pharmaceuticals Ltd (ASX: TLX) has been having a top run on the market lately....
Read ArticleTrawling through shares in the S&P/ASX 200 Index (ASX: XJO), we can at times forget what actual...
Read ArticleThe ASX 200 ended Tuesday 0.3 per cent lower at 7360 points after struggling to stage a midday comeb...
Read ArticleShareCafeASX recoups some earlier losses to close 0.29% lower by Peter Milios At the closing bell,...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) traded in the red on Tuesday, falling 0.29% to close at 7,360....
Read ArticleThe ASX slumped by 0.4% today as the RBA released its April minutes Core Lithium jumped 8pc after i...
Read ArticleIt’s been a pretty depressing day for ASX shares and the All Ordinaries Index (ASX: XAO) so far thi...
Read ArticleTelix (ASX:TLX) says olaratumab, an antibody licensed from Eli Lilly, has demonstrated proof...
Read ArticleMELBOURNE, Australia, April 17, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleMELBOURNE, Australia, April 17, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) ended the week on a high, rising 0.51% to finish the session a...
Read ArticleMELBOURNE, Australia, April 11, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) put on a rocky performance on Wednesday, eventually closing th...
Read ArticleIn a recent memo to investors, Wilsons equity strategist Rob Crookston pointed out how there are ma...
Read ArticleThe ASX swung into positive after the release of monthly CPI data Australia’s inflation has decline...
Read ArticleShareCafeGains from Energy and Materials boost ASX: Aus shares close 1% higher by Peter Milios At...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) started the week out on the right foot today, lifting 0.1% to...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes and updates...
Read ArticleThe medical imaging market size globally is forecast to reach $68.8 Billion by 2030 Several ASX hea...
Read ArticleSeveral ASX health stocks are seeking US FDA approval for drugs/devices in the near future Telix P...
Read ArticleFollowing FY22 results for Telix Pharmaceuticals brokers remain Buy-rated in light of an extensive p...
Read ArticleSaturday March 11 was a typical balmy autumnal afternoon in Melbourne, but Neuren (ASX:NEU) chief Jo...
Read ArticleASX health stocks fall 1.5% in the past five days, broader markets fall on global banking concerns...
Read ArticleThe ASX 50 drops 1.50% and ASX 200 loses 1.46% ABS say unemployment rate fell to 3.5% for February...
Read ArticleTelix Pharmaceuticals (TLX) has landed US FDA approval to image patients with metastatic prostate ca...
Read ArticleTelix Pharma gets FDA approval Prescient shows good data from Phase 1b clinical trial Incannex plan...
Read ArticleMELBOURNE, Australia, March 14, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) regained some of its Monday losses today, closing 0.47% higher...
Read ArticleThe final day of earnings season has seen a number of ASX 200 shares release their latest results....
Read ArticleMELBOURNE, Australia, Feb. 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleA three-week retreat in Australian shares looks set to continue this morning following falls on Wall...
Read ArticleTrial met primary and secondary endpoints and confirmed favourable safety and tolerability profil...
Read ArticleHighlights A new 100-day high for ASX 200 was noted at market close on 1 February 2023. The ASX...
Read ArticleASX health stocks rise 4.6% this week with positive signs of being back in favour Volpara soars aft...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) wobbled in and out of the green on Wednesday before ultimately...
Read ArticleThe share market inched to a new eight-and-a-half-month high as a strong start to the year continued...
Read ArticleThe ASX closed flat on Wednesday Local investors are closely watching earnings reports in both the...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At th...
Read ArticleAustralian shares marked time for a second day as a mixed night on Wall Street gave investors few re...
Read ArticleMELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ — 18 January 2023. Telix Pharmaceuticals Limited...
Read ArticleItâs a good day to own S&P/ASX 200 Index (ASX: XJO) biotech share Telix Pharmaceuticals Ltd (...
Read ArticleWorld Overnight SPI Overnight 7348.00 – 21.00 – 0.28% S&P ASX 200 7386.30 – 1.90 – 0.03%...
Read ArticleASX health stocks rise 0.8% this week as smaller names in sector show signs of being back in favour...
Read ArticleShareCafeAlmost all sectors lower despite signs of optimism in the US: ASX down 0.3% at noon by Pete...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end its winning streak. A...
Read ArticleThe share market sealed its longest win run since early November with a fourth straight rise followi...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a dece...
Read ArticleAussie shares hit a three-week high amid optimism about cooling inflation and China reopening. Th...
Read ArticleMELBOURNE, Australia, Jan. 9, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleThe share market snapped a run of four straight weekly declines following reports China may relax re...
Read ArticleResource stocks steered the ASX towards a third day of gains and a winning week to start 2023 despit...
Read ArticleASX 200 benchmark climbs 1.5% during an otherwise super-quiet day Tesla dives 12.2% and Apple slips...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) recovered from Tuesdayâs fall today, lifting 1.63% to close...
Read ArticleThe ASX had its first positive day of gains in 2023 Tesla could still be overpriced despite a 70% f...
Read ArticleA new year got off to a challenging start with Australian stocks at eight-week lows as a month-long...
Read ArticleIf youâre interested in adding some healthcare sector exposure to your portfolio, then it could b...
Read ArticleThe share market slumped to an eight-week low as signs of a sharp slowdown in major trading partner...
Read ArticleSoaring inflation and rising interest rates plagued share markets in 2022, ultimately sending the S...
Read ArticleEnding the year on a high note, the S&P/ASX 200 Index (ASX: XJO) rallied on the last trading da...
Read ArticleIf investors weren’t already sick of 2022, today’s performance of the S&P/ASX 200 Index (ASX: X...
Read ArticleHighights The ASX 200 benchmark index closed in the red today (December 29), losing 69.00 points...
Read ArticleThe share market closed at a seven-week low following solid falls on Wall Street amid fears of anoth...
Read ArticleThursday was another good day on the S&P/ASX 200 Index (ASX: XJO). It closed 0.53% higher at 7,...
Read ArticleComplete data from global Phase III ZIRCON study of Telix’s investigational imaging agent TLX25...
Read ArticleThe long and short of 2022 is that it was a frustrating period for the Australian biotech sector but...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) traded in the green on Tuesday, recovering some of yesterdayâ...
Read ArticleMELBOURNE, Australia, Dec. 5, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleOwen Rask and Drew Meredith are back on The Australian Investors Podcast for 2 Sense. This week, Dre...
Read ArticleAccording to Oxford Languages, âmotleyâ means âincongruously varied in appearance or characte...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) recovered yesterdayâs slump and then some today. It closed T...
Read ArticleMELBOURNE, Australia, Nov. 22, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) slipped on Tuesday as lithium stocks weighed on the market. Th...
Read ArticleNov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH...
Read ArticleTelix Pharmaceuticals (TLX) enters an agreement with Northern California PET Imaging Center to acqui...
Read ArticleNov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH...
Read ArticleNov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a volatile day. The biopharmaceutica...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ — Telix Pharmaceuticals L...
Read ArticleIt might be hard to believe after a crazy volatile 2022, but the S&P/ASX 200 Index (ASX: XJO) i...
Read ArticleMELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleShareCafeMaterials leads market higher: ASX up 0.6% at close by Peter Milios Materials is the stro...
Read ArticleHighlights: Australia’s highly comprehensive healthcare system consists of two broad categories...
Read ArticleShareCafeStrict Chinese measures dampen market sentiment: ASX up 0.29% at lunch by Lauren Hayes US...
Read ArticleSummary of Study Outcomes ZIRCON Phase III study of Telix’s investigational imaging agent TLX250...
Read ArticleAusBiotech and Johnson & Johnson Innovation Industry Excellence Awards Industry Leadership Awa...
Read ArticleMELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleMELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleAustralian shares were set to surge after hints of a slowdown in US interest rate rises fuelled a st...
Read ArticleThe ASX closed lower on Friday, extending its loss to over 1% for the week Coal and energy stocks g...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) ended the week in the red once more. The index fell 0.8% to 6,...
Read ArticleHighlights The ASX 200 benchmark index closed down today (21 October), losing 53.90 points or 0....
Read ArticleThe share market wrapped up a losing week with a second-straight decline as borrowing costs on both...
Read ArticleShareCafeGrim start to last trading day for the week: ASX down 0.8% by Peter Milios Energy and Inf...
Read ArticleA losing week on the ASX headed towards a downbeat conclusion as declines in banks and industrial co...
Read Article27 new biotech companies listed on the ASX the last two years Australian companies need access to U...
Read ArticleAustralian shares tracked Wall Street lower after the cost of borrowing rose and the jobs market sho...
Read ArticleAustralian shares fell for the first time in three sessions as record results from energy giants Woo...
Read ArticleIt’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with...
Read ArticleIn this week's Weekly Insights:-Investing In Non-Profitable Companies-Corporate Updates: Early Signa...
Read ArticleMELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleA strong lead-in from Wall Street gave solid impetus to the Australian market on Tuesday, and the re...
Read ArticleShareCafeEnergy only sector lagging: ASX closes 1.72% higher by Peter Milios The ASX has continued...
Read ArticleASX regains yesterday’s losses as volatility in the market continues All ASX sectors rose except En...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) jumped higher on Tuesday, driven by tech shares. The index end...
Read ArticleThe share market logged its highest close in a week and a half after a UK government backdown on a c...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday. In afternoon trade, the benchmark...
Read ArticleThe share market reversed yesterday’s loss after Wall Street welcomed a UK government decision to sc...
Read ArticleTelix (ASX:TLX) has announced that Health Canada has approved Illuccix gozetotide injection]...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) started the week out on the wrong foot. It fell 1.4% on Monday...
Read ArticleNew agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare’s immuno-...
Read ArticleTelix Pharmaceuticals (TLX) has expanded its partnership with GE Healthcare via a deal to supply its...
Read ArticlePatrys crosses blood brain barrier in health animals Cynata receives Notice of Acceptance from IP A...
Read ArticleMELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleASX healthcare shares have been a mixed bag in 2022. The industry was flourishing during the later...
Read ArticleHighlights The ASX 200 benchmark index closed up today, gaining 116.20 points or 1.75% to end at...
Read ArticleThe ASX finished almost 2% higher on Friday, flat for the week UK-exposed stocks rose on potential...
Read ArticleTelix Pharmaceuticals (TLX) gets approval from Health Canada for its imaging agent Illuccix for pros...
Read ArticleTelix granted approval in Canda EBR Systems halt trading, pending a manufacturing change announceme...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) closed in the red after spending most of today in the green. T...
Read ArticleDuring latest period of volatility many health stocks have seen their share prices remain quite sta...
Read ArticleHighlights: The S&P/ASX 200 closed significantly up on Wednesday (05 October 2022), gaining...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) recovered further from its September rout today. The index clo...
Read ArticleThe ASX gains another 1.7% on Wednesday All 11 sectors rose excepts Consumer Discretionary RBNZ rai...
Read ArticleThe Imugene Limited (ASX: IMU) share price had a rough month despite multiple clinical trial update...
Read ArticleTelix Pharmaceuticals (ASX: TLX) has announced it has withdrawn its application to market the compan...
Read ArticleMELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleTelix Pharmaceuticals (ASX:TLX) and GenesisCare, the largest provider of integrated cancer c...
Read ArticleShareCafeASX erases yesterday’s gains: Aus shares close 0.5% lower by Lauren Hayes It was choppy t...
Read ArticleHighlights: The ASX 200 benchmark index closed 0.53% lower to end at 6,462.00 points. Over the...
Read ArticleThe ASX was down 0.55% on Wednesday AUD drops below US64c RBA tells the ASX to improve its governan...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the day deep in the re...
Read ArticleShareCafeASX marginally lower: Aus shares down 0.3% at noon By Lauren Hayes The ASX gave up modest...
Read ArticleTelix Pharmaceuticals (TLX) has withdrawn its application to market its Illuccix product in EuropeTh...
Read ArticleHighlights The Australian shares opened higher on Wednesday. The ASX 200 index opened 14....
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a tumble on Wednesday. In morning tr...
Read ArticleMELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleMELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleShareCafeLunch Report: 27 September, 2022 by Lauren Hayes The ASX is trading higher this morning d...
Read ArticleMELBOURNE, Australia, Sept. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleTelix Pharma releases positive study results for TLX101 Imugene doses first patient in Phase 1 clin...
Read ArticleMELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Teli...
Read ArticleWhile there are many successful companies on the ASX that solely serve Australian consumers, there...
Read ArticleShareCafeEvening Report: 20 September, 2022 by Paul Sanger Australian shares posted solid gains, a...
Read ArticleHighlights The ASX 200 benchmark index closed up today, gaining 1.29% to end at 6,806.40 points....
Read ArticleAussie shares caught an up-lift from a general improvement in market mood as investors prepare for a...
Read ArticleAustralian home and business owners are now paying back more than two more percentage points in int...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) broke a two-session losing streak on Wednesday as energy share...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleMELBOURNE, Australia and NANTES, France, Aug. 24, 2022 /PRNewswire/ – Telix Pharmaceuticals Limit...
Read ArticleAustralian nuclear medicine company Telix Pharmaceuticals has reported a 726 per cent rise i...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) had a rough start to the week, but plenty of shares managed to...
Read ArticleTelix Pharmaceuticals' prostate cancer imaging product Illucix is quickly conquering the USA, but ma...
Read ArticleA busy week of corporate earnings faces a rocky start after Wall Street’s four-week winning run ende...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleShareCafeEvening Report: 18 August, 2022 by Paul Sanger At the closing bell, the S&P/ASX 200 w...
Read ArticleThe share market suffered its first setback in four sessions following weak US leads and as “messy”...
Read ArticleThe ASX 200 finished lower today Xero dragged down Tech sector Australia’s jobless rate is at 3.4%...
Read ArticleThe share market fell for the first time in four sessions following weak leads from Wall Street, dec...
Read ArticleRespiri gives update on US market Screening results from 19 of Emyria’s MDMA compounds have been re...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price plunged in early trade on Thursday after the c...
Read ArticleAussie stocks were poised to open lower following a volatile session in the US as investors assessed...
Read ArticleRecent cap raising suggests biotechs may finally be making a comeback Mesblast annnounced a US$45m...
Read ArticleShareCafeLunch Report: 12 August, 2022 by Paul Sanger At noon, the S&P/ASX 200 is 0.42 per cen...
Read ArticleJPMorgan’s equities desk is seeking buyers about a 3 per cent stake in ASX-listed Telix Pharmaceutic...
Read ArticleTelix (ASX:TLX) has announced that it has been jointly awarded a $4.8 million Australian Res...
Read ArticleMELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price finished the session on Friday up 0.52% to $7....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleShareCafeGlobal Biotech Turnaround Looks to Be Underway Signs of life are emerging in the global bio...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) slipped ever so slightly on Thursday after major commodity pri...
Read ArticleThe ASX 200 finished little changed after failing to sustain a push above 7000. The Australian be...
Read ArticleThe S&P/ASX 200 traded briefly above 7000 after oil fell to a six-month low and upbeat US econom...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) defied its earlier downturn to close higher after the Reserve...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has fought back and is edging slightly hi...
Read ArticleShareCafeLunch Report: 2 August, 2022 by Paul Sanger The Reserve Bank of Australia is expected to...
Read ArticleMELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleHighlights: WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 c...
Read ArticleHighlights: WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 c...
Read ArticleIn times of great uncertainty the Australian healthcare sector can offer investors plenty of choice,...
Read ArticleAfter a wobbly start to the day, the S&P/ASX 200 Index (ASX: XJO) posted a gain for the first...
Read ArticleThe share market logged its best week since March as a six-week high on Wall Street bolstered confid...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At...
Read ArticleShareCafeLunch Report: 22 July, 2022 by Paul Sanger The S&P/ASX 200 traded flat by midday in S...
Read ArticleAustralian shares gained momentum late morning, rising for a third session despite weak earnings fro...
Read ArticleShareCafeEvening Report: 21 July, 2022 by Paul Sanger At the closing bell, the S&P/ASX 200 was...
Read ArticleASX closes 0.30% higher after being in the red Lithium stocks rise on Tesla guidance Woodside down...
Read ArticleA late rally lifted the Australian share market to its strongest close in five weeks as strength in...
Read ArticleMelbourne-based Telix Pharmaceuticals says it made $19.3m in just 10 weeks after beginning US sales...
Read ArticleTelix Pharmaceuticals (TLX) reports more than a ten-fold quarter-on-quarter revenue increase for th...
Read ArticleThe share market hovered near a three-week high as declines in resource stocks outweighed gains in g...
Read ArticleShareCafeLunch Report: 21 July, 2022 by Paul Sanger Australian shares are little changed in mixed...
Read ArticleShareCafeStocks of the Hour: 21 July, 2022 Orthocell (ASX:OCC) recently signe...
Read ArticleAt lunch on Thursday, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline....
Read Article21 Jul 2022 - A snapshot of the stocks on the move featuring Orthocell (ASX:OCC), Telix Pharmaceutic...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is pushing higher in trade today. At the ti...
Read ArticleHighlights: ASX 200 stocks opened a little lower today, however, the benchmark index recovered a...
Read ArticleMELBOURNE, Australia, July 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleMach 7 announces patent infringement lawsuit settled in its favour Lumos Diagnostics tanks after d...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleASX biotech shares were hammered in FY22 with the sector facing heavy losses, in line with the wide...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced the appointment of a CEO for its Americas busi...
Read ArticleTelix Pharmaceuticals (TLX) appoints Kevin Richardson to the role of CEO Telix Americas The senior...
Read ArticleLumos’ FebriDX was rejected by the FDA Hexima hurt by unexpected readout from Phase 2 trial Anteris...
Read ArticleShareCafeLunch Report: 11 July, 2022 by Melissa Darmawan The fall in materials and information tec...
Read ArticleMELBOURNE, Australia, July 11, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleMELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX,...
Read ArticleThis month Iâve been looking at a number of shares that Bell Potter has rated as its top picks fo...
Read ArticleTelix Pharmaceuticals (TLX) signs a licence and distribution agreement with Isologic Innovative Pha...
Read ArticleAussie shares sank to their lowest level since November 2020 as recession fears continued to batter...
Read ArticleMELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX:...
Read ArticleMELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX:...
Read ArticleTelix Pharmaceuticals (ASX:TLX) and US-based RefleXion Medical have signed a new co-developm...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, June 13, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, June 10, 2022 /PRNewswire/ — Telix Pharmaceuticals Limite...
Read ArticleShareCafeLunch Report: 10 June, 2022 by Lauren Evans The Aussie sharemarket is off to another weak...
Read ArticleTelix Pharmaceuticals (TLX) signs a partnership for prostate cancer treatment with RefleXion Medica...
Read Article10 Jun 2022 - A snapshot of the stocks on the move featuring Bubs Australia (ASX:BUB), Telix Pharmac...
Read ArticleTelix Pharma’s Illucix could be used in BgRT radiotherapies in the US Chimeric Therapeutics advance...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has received a $17.25 million R&D tax refund from the fe...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited...
Read ArticleShareCafeEvening Report: 7 June, 2022 by Melissa Darmawan The cost of living is set to rise after...
Read ArticleHighlights XAO or All Ords entails the 500 largest companies on the ASX XAO is down by nearly 5...
Read ArticleAustralian shares suffered their heaviest loss in more than three weeks after the Reserve Bank raise...
Read Article07 Jun 2022 - A snapshot of the stocks on the move featuring, Yancoal (ASX:YAL), GQG Partners (ASX:G...
Read ArticleShares fell for a second day as downbeat economic data underlined cost of living pressures ahead of...
Read ArticleHighlights The Australian equity market opened lower today as the benchmark index ASX 200 index...
Read ArticleThe ASX 200 is set to open lower this morning RBA will announce interest rates decision at 2.30pm A...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited...
Read ArticleThe share market dropped 0.8 per cent following pressure on US stocks as the threat of significantly...
Read ArticleShareCafeEvening Report: 1 June, 2022 by Lauren Evans The Australian sharemarket held on to its ga...
Read ArticleMesoblast reports quarterly trading revenues Telix appoints new executives Osprey restructures busi...
Read ArticleShareCafeLunch Report: 1 June, 2022 by Lauren Evans The Aussie sharemarket is pushing higher this...
Read ArticleTelix Pharmaceuticals (TLX) announces a number of changes to its executive leadership team to enabl...
Read Article01 Jun 2022 - Darren Smith will take over Doug Cubbin as chief financial officer of Telix Pharmaceut...
Read ArticleShareCafeEvening Report: 30 May, 2022 by Lauren Evans The ASX 200 rose for a second successive day...
Read ArticleASX 200 was up 1.3% today, led by Tech which jumped 4% A2M rose 10% after Bubs got export deal wit...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is cha...
Read ArticleShareCafeLunch Report: 30 May, 2022 by Melissa Darmawan Australian shares jumped to a three week h...
Read Article30 May 2022 - A snapshot of the stocks on the move featuring Telix Pharmaceuticals (ASX:TLX), Austra...
Read ArticleInvion demonstrates high efficacy of INV043 when used as a combined therapy Biotron gets positive f...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, May 30, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited...
Read ArticleFriday has brought good news for embattled investors. DeVere Group CEO and founder Nigel Green has...
Read ArticleShareCafeLunch Report: 18 May, 2022 by Melissa Darmawan Materials lift ASX higher for 4th day Aust...
Read ArticleWorld Overnight SPI Overnight 7181.00 + 70.00 0.98% S&P ASX 200 7112.50 + 19.50 0.27% S&...
Read ArticleAustralian shares were poised to open higher for a fourth day after strong retail sales doused fears...
Read ArticleAustralian stocks were poised to open higher as lockdown news out of China over the weekend added to...
Read ArticleAustralian shares rebounded strongly this session but could not avert a fourth straight weekly decli...
Read ArticleA relief rally lifted the ASX 200 back above the 7000 level as a pause in this week’s bloodletting o...
Read ArticleYou might be sick of hearing this, but turbulent times like now mean it’s more important than ever...
Read ArticleThe share market logged its weakest close since January as the tech sector slumped to a two-year low...
Read ArticleHighlights: Race Oncology is riding high with governance approval for human trial of its new the...
Read ArticleBiotechnology ASX shares have been one of the biggest victims of persistent inflation and rising in...
Read ArticleSome of the worst-performing corners of the market enjoyed a day in the sun after a relief rally on...
Read ArticleTech and commodity stocks steered the share market towards its first gain of the week following Wall...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, May 5, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (...
Read ArticleHighlights Gains in the market were broad-based today with all the 11 individual sectors ending...
Read ArticleThe share market ended a volatile month on a strong note, advancing for a second day ahead of a like...
Read ArticleA broad rally carried the share market towards a second day of gains at the end of a challenging mon...
Read ArticleThe first few months of 2022 has seen share market volatility like we could not even imagine last y...
Read ArticleA week-long rally soured with the share market’s heaviest loss in two months as investors took profi...
Read Article22 Apr 2022 - Telix Pharmaceuticals (ASX:TLX) reported on its March quarter, with focus placed on it...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is sliding today and is now 1.96% in the red a...
Read ArticleThe share market backed off an eight-month high after a sharp reversal on Wall Street stoked risk av...
Read ArticleA disappointing quarterly from mining heavyweight BHP crimped a fifth day of share market gains as t...
Read ArticleASX 200 healthcare shares have struggled for the past six months, let’s face it. After peaking at 5...
Read ArticleAussie shares pared solid early gains as rising rates and stronger-than-expected Chinese consumer pr...
Read Article11 Apr 2022 - Telix Pharmaceuticals (ASX:TLX) has entered into a licence agreement with Eli Lilly, w...
Read ArticleTelix Pharmaceuticals (ASX:TLX) signs an exclusive licence agreement with Eli Lilly to develop its...
Read ArticleThe share market hit a four-session high before turning negative as US futures signalled potential w...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, April 11, 2022 /PRNewswire/ — Telix Pharmaceuticals Limite...
Read ArticleS&P/ASX 200 healthcare index modestly up 0.16% for week Gut health company Microba falls on IPO...
Read ArticleMELBOURNE, Australia, April 6, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleGains in the resources, banking and technology sectors contributed to a 6.9% total return for the AS...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced that its prostate cancer imaging agent Illucci...
Read ArticleASX 200 extends winning streak US bonds have sharply inverted, sparking concerns of a potential rec...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price took off today after the company released news...
Read ArticleThe share market ended within 80 points of this year’s highest close as a mining rally rolled on ami...
Read ArticleA lithium-led mining rally kept the ASX on track for this year’s highs. The S&P/ASX 200 cli...
Read Article04 Apr 2022 - A snapshot of the stocks on the move featuring Pepper Money (ASX:PPM), Telix Pharmaceu...
Read ArticleMELBOURNE, Australia, April 4, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleNon-Executive Director Oliver Buck to retire at the Annual General Meeting Tiffany Olson, expe...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limite...
Read ArticleHighlights The ASX 200 closed higher today, gaining 51.90 points or 0.70% to 7,464.30. Wall Str...
Read ArticleThe S&P/ASX Emerging Companies (XEC) Index is racking about 0.3% higher on Tuesday, while the be...
Read ArticleMELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limite...
Read ArticleASX 200 notched up sixth day of gains Retailers, tech were best performing sectors Fed Budget to be...
Read ArticleThe share market closed at a ten-week high as blue-chip healthcare, banking and consumer stocks took...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At th...
Read ArticleTech stocks took up the running as the Australian share market rose for a sixth session ahead of ton...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is heading north during late morning trade fol...
Read ArticleMELBOURNE, Australia and LIÈGE, Belgium, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited...
Read ArticleThe Australian market remains resilient to the threat of higher energy prices with the S&P/ASX 2...
Read ArticleThe share market sealed back-to-back weekly gains with a fourth straight advance after strong econom...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a high....
Read ArticleA rebound on Wall Street helped propel the ASX towards a fourth straight gain as a two-week mining r...
Read ArticleWith interest rates almost guaranteed to head upwards this year, multiple experts are emphasising p...
Read ArticleAustralian shares inched to a fresh nine-week high as strengthening commodity prices helped the mark...
Read ArticleMELBOURNE, Australia, March 23, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix,...
Read ArticleThe share market rallied to a two-month closing high, bolstered by rising commodity prices and the p...
Read ArticleTelix Pharmaceuticals (TLX) provides an update regarding the development of its radiopharmaceutical...
Read ArticleAustralia’s strength in natural resources fired the share market to a two-month high despite decline...
Read ArticleHighlights The benchmark ASX 200 was up 0.76% to 7,347.7 in the first 15 minutes of trading. US...
Read Article22 Mar 2022 - A snapshot of the stocks on the move featuring New Hope (ASX:NHC), Telix Pharmaceutic...
Read ArticleA third day of gains lifted the share market to its highest close in a month as a rebound in commodi...
Read ArticleTelix (ASX:TLX) has announced that its ZIRCON Phase 3 study of investigational kidney cancer...
Read ArticleThe S&P/ASX 200 (ASX: XJO) delivered another positive day despite the incredibly negative backdr...
Read ArticleToday, the S&P/ASX 200 Index (ASX: XJO) reclaimed the 7,000 point level, bucking the trend set...
Read ArticleThe Mesoblast Limited (ASX: MSB) share price has been regaining some of its recent losses today. I...
Read ArticleTelix Pharmaceuticals (TLX) completes target enrolment for its phase III ZIRCON study in patients w...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 1.90% at the time of writing, compared to the br...
Read Article08 Mar 2022 - A snapshot of the stocks on the move, featuring Home Consortium (ASX:HMC), Telix Pharm...
Read ArticleSYDNEY, March 3, 2022 /PRNewswire/ — Boutique investment and advisory firm Magnolia Capital has rele...
Read ArticlePresident Biden delivered his annual State of the Union address during the session, with strong comm...
Read ArticleHighlights The ASX 200 closed 0.3% higher, up 20.2 points to 7116.7 with most sectors lower asi...
Read ArticleThe major miners dug the share market out of a hole after soaring commodity prices helped drive Wall...
Read Article02 Mar 2022 - A snapshot of the stocks on the move featuring Mineral Resources (ASX:MIN), Transurban...
Read ArticleAustralia’s status as a commodities world-leader helped shield it from pressure on financial markets...
Read ArticleHighlights The benchmark ASX 200 index fell 0.68% to 7,047 in the first 15 minutes of morning tr...
Read ArticleToday, the S&P/ASX 200 Index (ASX: XJO) avoided negative territory after its worst fall in 17 m...
Read ArticleThe share market closed out its worst week since 2020 with a modest rebound as fighting in Ukraine a...
Read ArticleA massive overnight reversal on Wall Street and a strong trading update from Afterpay’s US parent co...
Read ArticleThe share market tumbled 3 per cent to its heaviest loss of the year after Russian troops attacked U...
Read ArticleThe share market slumped 2.5 per cent towards its second-heaviest loss of the year after the Dow clo...
Read ArticleShareCafeBuying Opportunities Beckon Amid Biotech Bloodbath The sharp retreat in global biotech valu...
Read ArticleSeven more capital raises were announced today, adding to the 89 ASX-listed companies that have rais...
Read ArticleTelix (ASX:TLX) had announced a commercial distribution agreement with Global Medical Soluti...
Read ArticleTelix Pharmaceuticals (TLX) enters into an agreement for the commercial distribution of its prostat...
Read ArticleAt the time of writing, the ASX 200 Health Index (XHJ) is up by over 4%, while the benchmark ASX 200...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced a global clinical supply agreement with Berlin...
Read ArticleThe ASX is hosting a goodbye party for Sydney Airport (ASX: SYD) on Wednesday as investors scramble...
Read ArticleTelix Pharmaceuticals (TLX) is granted an extension for its European regulatory review The notifica...
Read ArticleMedical imaging software Resonance Health (ASX:RHT) has received the green light in the US for its L...
Read ArticleToday, the S&P/ASX 200 Index (ASX: XJO) has further solidified its position above 7,000 points...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has entered an exclusive commercial distribution agreement w...
Read ArticleToday, the S&P/ASX 200 Index (ASX: XJO) was unable to reclaim lost ground throughout the day. A...
Read ArticleShareCafeWebinar Recap – LKE, TLX, EMH, ADV Catch up on the full webinar with presentations fr...
Read ArticleShareCafeTelix Pharmaceuticals (ASX: TLX) – Webinar Presentation Dr Christian Behrenbruch – CEO &am...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAustralian medical device company and global supplier of rapid diagnostic testing devices (RDT), Ato...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced that the first patient has been dosed in its p...
Read ArticleTelix Pharmaceuticals (TLX) has first patient dosed in its prostate-specific membrane antigen Telix...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has raised $175 million it says will be used to fund the pro...
Read ArticleFears of a market meltdown subsided early today as the ASX 200 fell by just 0.5%, lifted by the boun...
Read ArticleKey points The Telix Pharmaceuticals share price is down 13% on Monday The company’s December qua...
Read ArticleIn afternoon trade on Monday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week w...
Read ArticleTelix Pharmaceuticals (TLX) announces successful $175 million institutional placement which it says...
Read ArticleThe ASX 200 Health Index (XHJ) is falling by 0.3% at the time of writing, compared to the broader in...
Read ArticleMelbourne-headquartered nuclear medicine company Telix Pharmaceuticals (ASX: TLX) has completed a $1...
Read ArticleHealthcare and life sciences expert Scott Power,who has been a senior analyst with Morgans Financial...
Read ArticleTelix Pharmaceuticals (TLX) enters a trading halt while it plans an upcoming capital raise Currentl...
Read ArticleBearish sentiment is still gripping the local markets, but the ASX managed to pull into itself into...
Read ArticleASX-listed oncology company Telix Pharmaceuticals shares have gone into a trading halt as the group...
Read ArticleKey points ASX-listed Brainchip is flying higher again today after announcing another granted pate...
Read ArticleToday, the S&P/ASX 200 Index (ASX: XJO) took a ride to the downside with a powerful blow to tec...
Read ArticleToday, the S&P/ASX 200 Index (ASX: XJO) disappointed investors with another red showing. At the...
Read ArticleThe price action of ASX biotech shares was nothing short of a mixed bag in 2021. Several of the ma...
Read ArticleASX biotech shares were a mixed bag in 2021. Several of the majors came in behind their benchmarks...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read Article21 Dec 2021 - Telix Pharmaceuticals' (ASX:TLX) first patient has been dosed in a Phase I study of TL...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is continuing its good run this week amid a co...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At t...
Read ArticleTelix Pharmaceuticals’ (TLX) first patient has been dosed with TLX250-CDx for non-muscle invasive b...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is all over the place in early trade this morn...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.92% at the time of writing, compared to the br...
Read ArticleThe US Food and Drug Administration approves Telix Pharmaceuticals (TLX) prostate cancer imaging pr...
Read ArticleASX biotech shares provided a mixed bag of results in 2021 with many names underperforming their be...
Read ArticleThe ASX 200 closed Friday’s trading lower by 0.38%, but was still up 1.6% for the week. The local ma...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a disappoi...
Read ArticleShares in Melbourne-based oncology company Telix Pharmaceuticals Ltd (ASX: TLX) are currently down...
Read ArticleTelix Pharmaceuticals’ (TLX) marketing authorisation application (MAA) submission in Europe for the...
Read ArticleInvesting in ASX biotech shares was an underwhelming affair in November. As a basket, the sector la...
Read Article08 Dec 2021 - Telix Pharmaceuticals (ASX:TLX) has entered into an exclusive commercial distribution...
Read ArticleTelix Pharmaceuticals (TLX) enters an exclusive commercial distribution agreement with NUCLIBER S.A...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced an exclusive licence agreement for a novel pos...
Read ArticleTelix Pharmaceuticals (TLX) has been granted authorisation for Illuccix, the company’s lead prostat...
Read ArticleHe’s baaack! Fresh from founding and listing immune-oncology play Chimeric, Paul Hopper can add Radi...
Read ArticleHighlights The rising population and the rise in health issues are increasing the demand for hea...
Read ArticleHighlights Tissue Repair shares tumbled over 40% on its debut on the ASX. The stock price close...
Read ArticleHighlights The ASX closed 0.7 per cent lower, down 49.7 points to 7420.4. RBA Governor Philip L...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced that the first Australian patient has been dos...
Read ArticleThe TGA has approved Telix Pharmaceuticals' (ASX:TLX) lead prostate cancer imaging product,...
Read ArticleHighlights This health care stock delivered robust returns for investors this year. The stock s...
Read ArticleWhile you were watching the Melbourne Cup the ASX retreated, the RBA hinted an interest rate hike co...
Read ArticleASX biotech shares posted a month of solid gains in October, outpacing the wider market as a whole....
Read ArticleHighlights The ASX 200 traded 0.5% lower ahead of the RBA policy decision. Seven of 11 sectors...
Read ArticleHighlights The ASX 200 was up 0.3% this morning to 7,390. IAG has reduced its profit margin gui...
Read ArticleIntelicare nabs MercyCare contract for its AI sensor tech Telix scores TGA approval for prostate ca...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing dec...
Read ArticleTelix Pharmaceuticals (TLX) has received approval from the Australian drug watchdog for its prostat...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is charging higher, up 4.8% in morning trade t...
Read ArticleFollowing Wall Street’s record levels on Friday, the ASX 200 rebounded to rise by 0.6% today. All se...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced the first set of peer-reviewed results from th...
Read ArticleMoneyTalks is Stockhead’s regular recap of the stocks, sectors and trends that fund managers and ana...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 1.2% at the time of writing, compared to the broader index w...
Read ArticleHighlights The ASX 200 declined 0.9% by mid-session on Tuesday. Eight of the 11 sectors were in...
Read ArticleThe ASX 200 health stocks index (XHJ) is falling sharply by 2.40% at the time of writing, compared t...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleMarkets were calm and collected on Thursday, as the ASX 200 climbed by more than 1% following a stro...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on track to record a stellar gain on Thursday. In late afte...
Read ArticleThe S&P/ASX 300 Index (ASX: XKO) is pushing higher today, following a rebound after Monday’s he...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has plummeted today after the company announce...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read Article15 15 2021 - A snapshot of the stocks on the move, featuring Telix Pharmaceuticals (ASX:TLX), Hotel...
Read Article15 Sep 2021 - Telix Pharmaceuticals (ASX:TLX) will contribute to a US therapy trial, designed to tr...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is up almost 6% in early trade. Below, we take...
Read ArticleThe ASX 200 health stocks index (XHJ) fell by 0.90% at the time of writing, compared to the broader...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced an exclusive commercial distribution agreement...
Read ArticleWall Street snaps four-day losing streak In US stock markets, the S&P 500 rose by 0.23% and the...
Read Article13 Sep 2021 - Telix Pharmaceuticals (ASX:TLX) has found an Italian distribution partner for its pros...
Read ArticleHighlights Australian benchmark index, the ASX 200, traded higher by 0.3% by mid session. Five...
Read ArticleIn morning trade, the Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the rise. At the time...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced that the last patient has been imaged in a pha...
Read ArticleIn the spirit of the recently-concluded Olympics and ongoing Paralympics, congratulations to the bac...
Read ArticleHighlights ASX-listed healthcare companies rarely fail to bring joy to the market participants,...
Read ArticleClarity Pharmaceuticals (ASX:CU6) has become one of the biggest biotech IPOs in recent memory and ye...
Read ArticleHighlights Actinogen Medical has completed the global grant process for Xanamem with the officia...
Read ArticleHighlights Investing in renewable energy and clean energy ETFs could be a lucrative way to comba...
Read ArticleIkwezi Mining (ASX:IKW) topped the latest Running Hot list with a 14-day RSI of 82, after two straig...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares continue its upward trajectory, jumping 6% today. Can Te...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is soaring on the back of the company’s earnin...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced new collaborations and studies of its investig...
Read ArticleWhile today was a better day for the ASX than the past two days, the bourse still finished slightly...
Read ArticleThe ASX 200 fought back from a slow start to finish 0.12% lower in Wednesday trade, as local stocks...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has been a very strong performer on Wednesday....
Read ArticleHighlights Incannex Healthcare has filed a registration statement for a planned IPO (initial pub...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleHighlights Former L’Oreal MD to lead Live Verdure’s (ASX:LV1) ‘8 Seeds’ Skincare Dexus (ASX:DXS...
Read ArticleHighlights AVITA Medical disclosed that the US Food and Drug Administration (FDA) has authorised...
Read ArticlePaul Hopper has been behind a number of successful oncology biotechs, and his latest venture is one...
Read ArticleGlobal markets stay cool US stocks edged higher overnight to post their fifth straight day of gains...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced that it has received authorisation to decommis...
Read ArticleThe big end of town cooled off a bit to end the week, as mining stocks eased back while the broader...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a subdued...
Read ArticleMost ASX large cap sectors finished in the red today, in a topsy-turvy session which saw the ASX200...
Read ArticleThe ASX Healthcare index rose by 0.45% this morning, compared with the broader index which fell by 0...
Read ArticleHealthcare is a constantly changing industry in which you may be asking yourself if your investment...
Read ArticleGains for the technology sector spurred a 2.3% rise for the ASX200 in June, the eleventh month of ga...
Read ArticleAs we’ve covered extensively on the Fool over the past week, the S&P/ASX 200 Index (ASX: XJO) h...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSummary The benchmark index, ASX 200, had a decent run in June, with a ~2.4% growth. S...
Read ArticleOver the past month, a number of US FDA approvals have moved the share prices of global pharma stock...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIn late morning trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a po...
Read ArticleTelix Pharmaceuticals (ASX:TLX) says a first patient has been dosed in a phase one study of...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has been among the worst performers on the All...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIn early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form and trading lower. At...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is edging lower on Thursday morning despite th...
Read ArticleSummary Neuroprotective drug developer Argenica Therapeutics commenced trading on the ASX after...
Read ArticleOne area of the share market that is home to a number of quality options for investors is the mid c...
Read ArticleTech stocks push Wall Street near all-time highs All major US indices rose on Friday to close near t...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a negative day despite announcing an...
Read ArticleThe diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two tec...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is rocketing higher, nearing on its all-time h...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced that its bone marrow conditioning investigatio...
Read ArticleSummary Oncology firm Telix Pharmaceuticals has entered into an exclusive commercial distributio...
Read ArticleSummary Telix Pharmaceuticals signs distribution agreement with Germany based company Proteomic...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the move today. This follows the biotech...
Read ArticleTelix (ASX:TLX) has announced an exclusive commercial distribution agreement with Eckert &am...
Read ArticleTelix Pharmaceuticals (ASX:TLX) says it has been granted HREC approval and received CTN clea...
Read ArticleFor all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t chang...
Read ArticleSummary Oncology player Telix Pharmaceuticals has commenced Phase 3 clinical trial of its prosta...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price will be in focus today after the company annou...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced an agreement with Global Medical Solutions to...
Read ArticleWall Street bounces back All major indices in the US have bounced back, after falling the previous d...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has the wobbles today after the company shared...
Read ArticleGlobal equities tumble All major world indices tumbled overnight as COVID-19 deaths spiked in India...
Read Article19 Apr 2021 - Telix Pharmaceuticals (ASX:TLX) has announced the launch of the "Nobody Left Behind" (...
Read ArticleSource: Have a nice day Photo, Shutterstock Summary Telix Pharmaceuticals has announced the lau...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is storming higher this morning. At the time o...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced an agreement with contract development and man...
Read Article31 Mar 2021 - Telix Pharmaceuticals (ASX:TLX) has completed an agreement with contract development a...
Read ArticleMichael Gable is an expert guest commentator for the Finance News Network, presenting “Stock Watch”...
Read ArticleSource: Enjoy The Life, Shutterstock Summary ASX 200 increased 0.8% on Friday, however it edged...
Read ArticleSource: Josep Suria, Shutterstock Healthcare, one of the biggest and most convoluted sectors in th...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is sliding 4.3% today after the company release...
Read ArticleTelix Pharmaceuticals (ASX.TLX) has announced that its Japanese subsidiary and partner Kanaz...
Read ArticleAustralian company Telix Pharmaceuticals (ASX:TLX) has announced the Ministry of Health of t...
Read ArticleSummary Telix Pharmaceuticals has obtained national authorisation for its prostate cancer imagin...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced a research cooperation agreement with Heidelbe...
Read ArticleThe OC Micro-Cap Fund was a strong performer during the final quarter of 2020. According to its mos...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the week strongly. At...
Read Article25 Jan 2021 - Bio-tech company Telix Pharmaceuticals (ASX:TLX) Phase 3 clinical trial of its renal c...
Read ArticleWill the share price of Telix Pharmaceuticals Ltd (ASX: TLX) go up after announcing patient news? Wh...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has come under pressure on Monday morning and...
Read ArticleTelix Pharmaceuticals (ASX:TLX) and partner ARTMS have announced they have successfully prod...
Read ArticleOver the past 12 months, the Telix Pharmaceuticals Ltd (ASX: TLX) share price has posted massive ga...
Read ArticleTelix Pharmaceuticals plans to accelerate development of its radiopharmaceutical to treat the most a...
Read ArticleSummary Biopharmaceutical player Telix Pharmaceuticals files a New Drug Submission for TLX591-CD...
Read ArticleBiopharma Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading lower this morning, despite t...
Read ArticleSummary The intensity of adoption of tech-enabled health solutions has shot up amidst government...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading lower at open today, despite a posi...
Read ArticleThe TGA has granted Telix Pharmaceuticals' (ASX:TLX) prostate cancer imaging product TLX591-...
Read ArticleImage Source: Shutterstock Summary Telix Pharmaceuticals announced that its application for TGA...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is slipping today, down 2.5% in afternoon trad...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher after the company announced a...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) has given back its morning gains and is dro...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher again on Wednesday after the...
Read ArticleAustralian biotechnology company Telix Pharmaceuticals has announced it will acquire Swiss-G...
Read ArticleSummary Telix signed an agreement with Scintec to acquire TheraPharm GmbH. An upfront payment o...
Read Article30 Nov 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into an agreement with Scintec Diagnostics...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) has given back its early gains and is dr...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has returned from its trading halt and is stor...
Read ArticleThe All Ordinaries index may be racing higher this month, but its 11% gain pales in comparison to s...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has filed a new drug application with the US FDA for its rad...
Read ArticleSummary ASX-listed biopharmaceutical company Telix Pharmaceuticals has received the FDA green li...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another strong ga...
Read ArticleTelix Pharmaceuticals Ltd (ASX: TLX) shares are rocketing higher this morning after the company ann...
Read ArticleTom Bleakley, BW Equities BUY RECOMMENDATIONS Telix Pharmaceuticals (TLX) This research and develo...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a very strong gain....
Read ArticleTelix Pharmaceuticals (ASX:TLX) has entered a strategic commercial partnership with China Gr...
Read ArticleThe Melbourne-headquartered biopharmaceutical company is focused on developing a portfolio of clinic...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) started the week in fine form and charged higher on Monday. Th...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has started the week with a bang, rocketing by...
Read ArticleHere’s the kind of late Friday afternoon announcement anyone who’s left paying attention loves to st...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) is dropping lower and on course to end i...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has been a strong performer on Tuesday. In mor...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a ver...
Read ArticleIt has been a disappointing day of trade for the S&P/ASX 200 Index (ASX: XJO) on Thursday. At t...
Read ArticleThe market may be dropping lower today but that hasn’t stopped the Telix Pharmaceuticals Ltd (ASX:...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has submitted a New Drug Application to the US FDA for its r...
Read ArticleNuclear oncology company Telix Pharmaceuticals (ASX:TLX) says the first two patients with advanced l...
Read ArticleI think the healthcare sector is a great place to look for buy and hold options. This is because in...
Read Article03 Sep 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a strategic collaboration agreement w...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another strong gain....
Read ArticleJobkeeper subsidies will make up two thirds of dental group 1300 Smiles’ (ASX:ONT) final dividend at...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleOne area of the share market which I believe is home to a number of promising small caps is the hea...
Read ArticleIt has been a busy day of quarterly update releases on the Australian share market. And while the l...
Read ArticleTelix Pharmaceuticals (ASX:TLX) says it has entered into a strategic collaboration agreement...
Read ArticlePharmaceutical company Althea Group (ASX:AGH) had some interesting distribution news, announcing the...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has jumped by 16.02% today on the back of a ma...
Read Article01 Jul 2020 - Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration (FDA)...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on course to start the new financial year with a solid gain...
Read ArticleClinical-stage biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has received confirmation...
Read ArticleShareCafeHidden Gems Webinar Recap – MMM, NCZ, ALC, TLX We continue to unearth micro and small-cap c...
Read ArticleTelix Pharmaceuticals (US) Inc, a subsidiary of Telix Pharmaceuticals Limited (ASX: TLX) announced o...
Read Article15 May 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a commercial distribution agreement w...
Read ArticleOne area of the market that I think is a good place to look for buy and hold options is the small e...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is on watch this morning following an announce...
Read ArticleThe market carnage is certainly proving a great buying opportunity for directors, with even more las...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading slightly higher on Tuesday after th...
Read ArticleJumbo Interactive (ASX:JIN) has added MS (Multiple Sclerosis) Queensland to its cohort of charity lo...
Read ArticleTelix Pharmaceuticals (TLX) has received approval from the U.S. Food and Drug Administration for th...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has been a strong performer on Thursday. In mo...
Read ArticleYou may have heard the saying “it’s not brain surgery” in the context of trying to prove something e...
Read ArticleThe health sector was the most successful sector on the ASX in 2019. Various small caps made several...
Read ArticleTelix Pharmaceuticals (TLX) has submitted a clinical briefing package to the U.S. FDA for its prost...
Read ArticleTelix Pharmaceuticals (TLX) has submitted a phase 3 Investigational New Drug application to the U.S...
Read ArticleInvion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. T...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is pushing higher in morning trade. At the tim...
Read ArticleI wanted to take this opportunity, on behalf of the whole team here at The Motley Fool, to wish all...
Read ArticleASX pharma group Telix Pharmaceuticals Ltd (ASX: TLX) is one company worth watching this morning. T...
Read Article20 Dec 2019 - Biopharmaceutical company, Telix Pharmaceuticals (ASX:TLX) is pleased to announce that...
Read ArticlePharmaxis (ASX:PXS) has some big news from its German partner, but won’t yet say whether it’s good o...
Read ArticleOn 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, w...
Read ArticleDrug Development Process The drug development process starts from drug discovery and ends at the lau...
Read ArticleOne of the oldest tropes in journalism is the miracle cure. Startup Daily is old enough to remember...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price has dropped lower with the market on Wednesday...
Read ArticleSee our brand new top 10 broker reviews. Find your perfect platform! Tom Bleakley, BW Equities BUY R...
Read ArticleOne area of the market that I think is a good place to look for buy and hold options is the small e...
Read Article07 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) today announced that Dr David Cade has joined the Teli...
Read ArticleTelix Pharmaceuticals Limited (ASX: TLX) has entered into conditional purchase agreement with Eckert...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is one to watch in early trade after the comp...
Read Article03 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) has entered into a conditional purchase agreement with...
Read ArticleHealth care industry Australian health care industry is not just on a strong growth path but also co...
Read ArticleImagion Biosystems: Breakthrough Device By Pitt Street Research An innovative medical device company...
Read ArticleASX code: IBX Market cap: $12.95m Share price: 4c Shares on issue: 323,705,324 Chairman and CEO: Bob...
Read ArticleOne area of the share market which I think has strong long term growth potential is the healthcare...
Read ArticleOn Friday the Mayne Pharma Group Ltd (ASX: MYX) share price has dropped to within a whisker of a mu...
Read ArticleTelix Pharmaceuticals (ASX:TLX) has announced subscriptions under its Share Purchase Plan (S...
Read ArticleThe PolyNovo Ltd (ASX: PNV) share price was amongst the best performers on the All Ordinaries index...
Read ArticleBiopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has been given the green light to commenc...
Read ArticleShares in Immuron took a 17 per cent hit this morning after the company revealed its IMM-124E drug d...
Read ArticleEver since its 2018 initial public offering the Telix Pharmaceuticals Ltd (ASX: TLX) share price ha...
Read ArticleZelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results f...
Read ArticleThe local biotech sector is fall of landmines able to blow up your capital at any time as most biot...
Read ArticleOne area of the market which I think is home to a number of promising small cap shares is the healt...
Read ArticleASX shares at the smaller end of the market are outperforming along with the Australian dollar as t...
Read ArticleMelbourne-based Telix Pharmaceuticals (ASX:TLX) has announced the successful completion of a...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price closed 4.2% lower on the ASX yesterday as the...
Read ArticleThe biotechnology sector is one of those sectors that presents an incredible opportunity for huge re...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe below-mentioned healthcare stocks have provided significant returns in the last six months and h...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price is now up 157% over 2019 from 65 cents at the...
Read ArticleThe Elders Ltd (ASX: ELD) share price won’t be going anywhere today after the agribusiness company...
Read ArticleTaylor Collison and Wilsons are in the market with a $40 million equity raising for Telix Pharmaceut...
Read ArticleWhen it comes to investing in world class healthcare companies, the Australian share market offers ...
Read ArticleBecause of positive tailwinds such as ageing populations, increased chronic disease burden, and bet...
Read ArticleWith the Australian share market hitting an 11 and a half year high on Wednesday, it will not be a...
Read ArticleThe Telix Pharmaceuticals Ltd (ASX: TLX) share price soared 16% today to a record high of $1.16 afte...
Read ArticleThe Australian Healthcare System is amongst the most inclusive in the world, and it offers a wide ra...
Read ArticleMelbourne-based Telix Pharmaceuticals (ASX:TLX) has announced the extension of its research...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
